Emerging information on the link between ovarian cancer and endometriosis gives us an unprecedented opportunity to develop comprehensive screening plans for early detection and prevention of specific types of ovarian cancer. More »
Human papillomavirus vaccines provide still some benefit to women who have undergone treatment for HPV-related diseases, according to a new study published in the British Medical Journal. More »
New screening guidelines for the prevention and early detection of cervical cancer are now largely based on the patient’s age, and testing for HPV DNA has now been incorporated into the screening process. More »
A study published today details a scoring system that may predict which ovarian cancer patients responded to first-line platinum chemotherapy based on a DNA-repair pathway-focused score. The score is based on a gene expression profile of 23 DNA-repair genes that normally function to repair... More »
New screening guidelines for the prevention and early detection of cervical cancer are now largely based on the patient’s age and, for the first time, testing for human papillomavirus (HPV) DNA has been incorporated into the screening process. More »
CancerNetwork interviews two prominent ovarian cancer researchers from both sides of the Atlantic on the role of PARP inhibitors and the challenges of developing ovarian cancer therapies. More »
Diffusion-weighted MRI is the most effective MRI technique to detect and evaluate patient response to platinum-based neoadjuvant chemotherapy for late-state ovarian cancer. More »
This article reviews the trials that have been conducted with PARP inhibitors in epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer, and places the impact of those results in the larger context of PARP inhibitor development. More »
the Central American Federation of Associations and Societies of Obstetrics and Gynecology, the Gynaecologic Oncologists of Canada, the Society of Canadian Colposcopists, the Society of Gynecologic Oncologists, and the Royal College ... of Associations
276 l MARCH JOGC MARS 2012 SOGC COMMITTEE OPINION Genetic Considerations for a Womans Annual Gynaecological Examination No. 273, March 2012 This document reflects the emerging clinical and scientific advancement on the date issued and is subject
Podrasky, MD11; Leslie M. Scoutt, MD12; Carolyn M. Zelop, MD.13 Summary of Literature Review Ovarian cancer accounts for about 3 of cancers in American women but is the leading cause ... of death from gynecologiccancers and is the fifth leading cause of
MARCH JOGC MARS 2012 l S1 OPINION DE COMIT DE LA SOGC Facteurs gntiques prendre en considration dans le cadre de lexamen gyncologique annuel N 273, mars 2012 La prsente opinion de comit a t rdige par le comit sur la
Cancer survivors have a greater risk for new cancers compared with persons who have never had cancer ( 11, 12). ... care after a cancer diagnosis ( i.e., survivorship care plans) ( 19) have shown evidence of the ability to prevent new cancers or cancer
Breast, prostate, and colorectal cancers were the most common types of cancer among survivors, accounting for 51% of diagnoses. ... Female breast ( 22.1%), prostate ( 19.4%), and colorectal ( 9.5%) cancers were the most common types of cancer diagnosed,
. Search The CDC. Search Button. Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: Text size:. Add this
Would agree with Dan I usually want an IVP (although the radiologists thing CT is great for this as well) to see kidneys number location ureters etc. But you may have already done that. Joanne Joanne Bulley, MD, FACOG Keene, NH
This is a multipart message in MIME format. =_alternative 00613E1D88257A01 Except the Digene hybrid capture DNA test is a Chemi luminescent assay (not SEMI-luminescent!). Need more sleep! :) /tj NOTICE TO RECIPIENT: If you are not the intended recipient of this e-mail, you are prohibited from sharing, copying, or otherwise using or disclosing its contents. If you have received this e-mail in error, please notify the sender immediately by reply e-mail
(ID_jjsvFwBAqvphbZO+JTgAYA) Could consider HTA ablation, does not require normal cavity. ************************************************************************* Charlie Chambers Hood River, OR No matter where you go... there you are. Dr. Buckaroo Banzai ************************************************************************ On May 16, 2012, at 5:13 PM, Garry E. Siegel, M.D. wrote: (ID_jjsvFwBAqvphbZO+JTgAYA) Could consider HTA ablation, does not require normal cavity. ************************************************************************* Charlie Chambers Hood River, OR "No matter where you go... there you are." Dr. Buckaroo Banzai ************************************************************************ On May 16,
. Azithromycin Associated with Cardiovascular Death The antibiotic azithromycin — which may have proarrhythmic properties — is associated with increased risk for cardiovascular death, according to a retrospective cohort study in the New England Journal of Medicine. The study, in a Medicaid population, included nearly 350,000 azithromycin prescriptions, 1.4 million control periods without antibiotic prescriptions, and 1.8 million prescriptions for other antibiotics, mostly amoxicillin. Azithromycin conferred a nearly threefold increase in
35 YO P4004 presents with longstanding menorrhagia, and requests a hysterectomy. OCPs not successful due to side effects, DepoProvera declined. She has a Mullerian abnormality such that I do not think Mirena or ablation are appropriate. I don't remember all of the details regarding her initial evaluation that I did in 1995, but I do have the op note. 19 YO P0, monthly cycles, presented with bleeding through a tampon. On
Physician Performance Goals Are Great, But Balance Is More Realistic Jennifer Frank, MD, May 15, 2012 Performance measurements for physicians are well-intentioned and get me to rethink how I practice. But in the end I won't make the goals, so I'll have to go with balance over perfection.
Designing the Perfect Business Card for Your Medical Practice C. Noel Henley, MD, May 11, 2012 Does your business card say anything substantive about the valuable work you do in your practice? Here’s how to re-design your next business card for maximum impact and engagement.
Registered Nurses an Ideal Fit for Primary Care Practices Audrey "Christie" McLaughlin, RN, May 10, 2012 Here are four good reasons to hire a registered nurse for your primary care practice …maybe even instead of a medical assistant.
The Five Biggest Medical Practice Marketing Mistakes James Doulgeris, May 10, 2012 There are best practices to marketing your practice, but often, success is more about knowing what not to do. Here are the five most common pitfalls …and how to avoid them.
Can You Practice Medicine and Manage Your Practice? Rosemarie Nelson, May 9, 2012 Whether you practice alone, or in a group, if you're trying to see patients in this pay-for-volume environment and also run the business of your practice, you may be missing out on important opportunities.
